Schizophrenia (SCZ) and Manic-Depressive Illness (MDI) are devastating psychiatric syndromes, affecting at least 1% of the American population. Family, twin and adoption studies conducted over the past half century consistently implicate heredity in the pathogenesis of these illnesses. Linkage analyses with DNA markers - coupled with novel candidate gene studies - holds great promise to elucidate the genetics of neurobiology of some forms of SCZ and MDI. Previous grant support, from both private and ADAMHA sources, has allowed Dr. Byerley to ascertain 12 multiplex schizophrenia pedigrees as well as 12 high density bipolar families. During the course of this work, Dr. Byerley conducted over 500 SADS-L interviews and over 150 follow-up SADS-L interviews. In addition, Dr. Byerley coordinated candidate gene studies (e.g., the D1, D2, D3, D4, and D5 dopamine receptors) as well as genome scanning techniques in a subset of pedigrees. The primary aim of Dr. Byerley's work is to test the hypothesis that major loci underlie SCZ and MDI in a subgroup of families. this will be carried out by (1) ascertaining at least eight additional SCZ pedigrees as well as eight MDI families and (2) genotyping studies with highly polymorphic simple sequence repeat markers, polymorphic brain cDNAs, and selected candidate genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research (K02)
Project #
5K02MH001089-02
Application #
2240476
Study Section
Epidemiology and Genetics Review Committee (EPI)
Project Start
1993-08-01
Project End
1998-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Utah
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Segurado, Ricardo; Detera-Wadleigh, Sevilla D; Levinson, Douglas F et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73:49-62
Lewis, Cathryn M; Levinson, Douglas F; Wise, Lesley H et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48
Coon, H; Myles-Worsley, M; Tiobech, J et al. (1998) Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol Psychiatry 3:521-7
Freedman, R; Coon, H; Myles-Worsley, M et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94:587-92
Fang, N; Coon, H; Hoff, M et al. (1995) Search for a schizophrenia susceptibility gene on chromosome 18. Psychiatr Genet 5:31-5
Hadley, D; Hoff, M; Holik, J et al. (1995) Manic-depression and the norepinephrine transporter gene. Hum Hered 45:165-8
Gregor, P; Hoff, M; Holik, J et al. (1994) Dinucleotide repeat polymorphism in the human taurine transporter gene (TAUT). Hum Mol Genet 3:2263
Byerley, W; Hoff, M; Holik, J et al. (1994) A linkage study with D5 dopamine and alpha 2C-adrenergic receptor genes in six multiplex bipolar pedigrees. Psychiatr Genet 4:121-4
Pariseau, C; Gregor, P; Myles-Worsley, M et al. (1994) Schizophrenia and glutamate receptor genes. Psychiatr Genet 4:161-5